Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses하이드록시클로로퀸과 아지스로마이신의 병용 치료는 항암 면역 반응의 치료 유도와 양립 가능합니다.Article Published on 2020-07-082022-09-11 Journal: Oncoimmunology [Category] SARS, 바이오마커, 비임상, 신약개발, 임상, [키워드] administration Affect antibiotic anticancer antimalarial antimalarial drug appear autophagic flux AZI Azithromycin blockade body weight breath Campus Cancer Cancer patients cancers cisplatin clinical trial Combination combination therapy COVID-19 crizotinib curative dose doses Gustave Roussy HCQ Hydroxychloroquine immune immune checkpoint immune response immune responses immunogenic cell death Immunotherapy indicated inducer interfere investigated lung cancer mice not affect oxaliplatin PD-1 preclinical study reduction in regimen SARS-CoV-2 therapeutic treated Treatment Tumor tumor growth utility [DOI] 10.1080/2162402X.2020.1789284 PMC 바로가기 [Article Type] Article
Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocyclineArticle Published on 2011-04-122024-09-04 Journal: Experimental neurology [Category] 대상포진, [키워드] Chemotherapy intraepidermal nerve fiber Minocycline Neuropathy oxaliplatin [DOI] 10.1016/j.expneurol.2011.02.019 PMC 바로가기 [Article Type] Article